Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Understanding the differences between value and growth investing is essential. Learn how to choose the right approach for your goals.
24,909 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Regulated XRP ETFs have opened a convenient on-ramp to Ripple exposure. This story breaks down how (ripple) beginners...
A director at The Cheesecake Factory recently disclosed a sizable stock move. This guide breaks down what that inside...
Imagine stock dividends automatically buying Bitcoin inside an ETF. Franklin Templeton reportedly explored a dividend...
The race to secure rare earths is reshaping U.S. investing. This article breaks down whether rare earth stock: buy US...
Chip Wilson, founder of Lululemon, remains a disruptive voice as he pushes for board changes while the company prepar...
A stock down 2026 can still offer surprises. This guide breaks down bear, base, and bull scenarios for the next three...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
Ethereum has cooled after a rapid rally, but a dip below $1,000 doesn’t have to derail your strategy. This practical ...
Lamborghini posted a record year for deliveries in 2025, but import tariffs trimmed profits and narrowed margins. The...
Gold has shifted from peak highs to a challenging bear phase. This guide breaks down how to spot a buying opportunity...
Two Kalshi veterans are raising up to $35 million for a new prediction-market VC fund called 5c(c) Capital, backed by...